Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764159
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of WarsawNot Yet RecruitingNot Applicable
NCT07764159Not Yet Recruiting
Not Applicable
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of War...
NCT07763717
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIALAlma Mater Europaea - SloveniaNot Yet RecruitingNot Applicable
NCT07763717Not Yet Recruiting
Not Applicable
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE...Alma Mater Europaea - Slo...
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
NCT07763977
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive DisorderGuangdong Provincial People's HospitalEnrolling By InvitationNot Applicable
NCT07763977Enrolling By Invitation
Not Applicable
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on In...Guangdong Provincial Peop...
NCT07762053
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor TonometerEyeCBetter CorporationNot Yet RecruitingNot Applicable
NCT07762053Not Yet Recruiting
Not Applicable
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomon...EyeCBetter Corporation
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07762560
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockBoston Scientific CorporationNot Yet RecruitingNot Applicable
NCT07762560Not Yet Recruiting
Not Applicable
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter...Boston Scientific Corpora...
NCT07762482
Periodontal Tissue Stability After Surgical Correction of Altered Passive EruptionUniversity of Sao PauloRecruitingNot Applicable
NCT07762482Recruiting
Not Applicable
Periodontal Tissue Stability After Surgical Correction of Altered Passive Erupti...University of Sao Paulo
NCT07763912
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763912Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762235
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive ImpairmentIstinye UniversityNot Yet RecruitingNot Applicable
NCT07762235Not Yet Recruiting
Not Applicable
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive Impairme...Istinye University
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763015
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals, Inc.Not Yet RecruitingPhase 2
NCT07763015Not Yet Recruiting
Phase 2
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals,...
NCT07763041
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, Maternal Attachment, and Infant Health in the NICUAnkara Medipol UniversityCompletedNot Applicable
NCT07763041Completed
Not Applicable
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, M...Ankara Medipol University
NCT07764211
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health CenterNot Yet Recruiting
NCT07764211Not Yet Recruiting
—
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health Ce...
NCT07762781
Impact of a Mobile Exercise Application on Sleep, Pain, and Fitness in Healthy AdultsTokat Gaziosmanpasa UniversityCompletedNot Applicable
NCT07762781Completed
Not Applicable
Impact of a Mobile Exercise Application on Sleep, Pain, and Fitness in Healthy A...Tokat Gaziosmanpasa Unive...
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
NCT07762027
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly BiosciencesNot Yet RecruitingPhase 2
NCT07762027Not Yet Recruiting
Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Part...Assembly Biosciences
NCT07762508
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low-Performance or High-Comorbidity AML Patients in CR1The First Affiliated Hospital of Soochow UniversityNot Yet RecruitingNot Applicable
NCT07762508Not Yet Recruiting
Not Applicable
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low...The First Affiliated Hosp...
Result Breakdown
Not yet recruiting11 (55%)
Completed6 (30%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable15 (75%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)
Not Specified1 (5%)